Nascent Pharma Holdings, Inc. (NASC)
OTCMKTS · Delayed Price · Currency is USD
0.0129
-0.002525 (-16.37%)
At close: Jun 12, 2026
Nascent Pharma Holdings Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -13.26 | -9.74 | -14.92 | -12.17 | -8.88 | -5.9 |
Depreciation & Amortization | 0.69 | 1.4 | 1.43 | 0.54 | 0.78 | 0.24 |
Other Amortization | 1.38 | 1.42 | 0.44 | 1.64 | 0.27 | - |
Loss (Gain) From Sale of Assets | 3.14 | - | 0.31 | - | -0.15 | - |
Asset Writedown & Restructuring Costs | 0.72 | - | 0.25 | - | 0.94 | - |
Stock-Based Compensation | 1.29 | 3.09 | 9.55 | 5.05 | 2.58 | 4.4 |
Provision & Write-off of Bad Debts | 3.79 | 1.83 | 0.75 | 0.06 | 0.27 | 0.25 |
Other Operating Activities | 0.69 | 0.02 | -0.08 | 0 | 0.45 | -0.01 |
Change in Accounts Receivable | 1.4 | 1.03 | -3.69 | -1.71 | -1.02 | -1.47 |
Change in Inventory | 0.8 | 0.58 | 0.53 | -2.21 | 0.93 | -0.21 |
Change in Accounts Payable | -0.47 | -0.95 | 1.99 | 1.01 | -0.63 | 0.15 |
Change in Other Net Operating Assets | 0.06 | 0.02 | -0.52 | 0.31 | 2.5 | 0.13 |
Operating Cash Flow | 0.25 | -1.3 | -3.95 | -7.47 | -1.95 | -2.41 |
Capital Expenditures | - | -0.02 | - | -0.54 | -0.05 | -1.11 |
Sale of Property, Plant & Equipment | - | - | - | - | 0 | - |
Sale (Purchase) of Intangibles | - | - | - | -0.18 | - | -0.55 |
Other Investing Activities | -0.01 | -0.07 | - | - | 0.02 | -0 |
Investing Cash Flow | -0.01 | -0.08 | - | -0.72 | -0.03 | -1.66 |
Short-Term Debt Issued | - | 0.06 | 0.08 | 0.22 | - | - |
Long-Term Debt Issued | - | 2.41 | 3.45 | 1.63 | 4.52 | 0.04 |
Total Debt Issued | 0.41 | 2.47 | 3.53 | 1.84 | 4.52 | 0.04 |
Long-Term Debt Repaid | - | -0.94 | -0.38 | -0.22 | -1.36 | -0.02 |
Total Debt Repaid | -0.67 | -0.94 | -0.38 | -0.22 | -1.36 | -0.02 |
Net Debt Issued (Repaid) | -0.26 | 1.53 | 3.15 | 1.62 | 3.16 | 0.02 |
Issuance of Common Stock | - | - | 0.5 | 6.56 | 0.3 | 3.3 |
Repurchase of Common Stock | - | - | - | - | -0.56 | - |
Other Financing Activities | - | -0.18 | -0.08 | - | -0.52 | - |
Financing Cash Flow | -0.26 | 1.35 | 3.57 | 8.17 | 2.38 | 3.31 |
Net Cash Flow | -0.02 | -0.04 | -0.38 | -0.01 | 0.41 | -0.76 |
Free Cash Flow | 0.25 | -1.32 | -3.95 | -8.01 | -2 | -3.52 |
Free Cash Flow Margin | 23.85% | -61.21% | -59.04% | -173.90% | -116.82% | -152.63% |
Free Cash Flow Per Share | 0.01 | -0.10 | -1.11 | -5.96 | -8.48 | -25.64 |
Cash Interest Paid | - | - | 0.08 | 0 | 0.21 | 0.01 |
Cash Income Tax Paid | - | - | 0 | 0 | 0 | 0 |
Levered Free Cash Flow | 1.67 | 1.35 | -0.46 | -1.84 | -0.8 | -3.44 |
Unlevered Free Cash Flow | 1.89 | 1.5 | -0.34 | -2.17 | -0.49 | -3.44 |
Change in Working Capital | 1.8 | 0.68 | -1.69 | -2.6 | 1.78 | -1.4 |